Phosphatidylserine Data Limited To Dementia Mitigation Not Prevention – FDA

All the data submitted to FDA in support of a health claim linking phosphatidylserine to prevention of dementia or cognitive dysfunction examine the ingredient's ability to mitigate the conditions in a diseased population, not on reducing risk in the general population, the agency said in a May 13 letter